首页> 外文期刊>Drug metabolism and drug interactions >Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics.
【24h】

Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics.

机译:饮食中多酚类药物诱导的癌症化学预防和凋亡机制。

获取原文
获取原文并翻译 | 示例
           

摘要

This review summarises current knowledge on the various molecular chemopreventive or therapeutic mechanisms that may be involved when the administration of flavonoids or polyphenols prevented chemical carcinogenesis in animal models. These mechanisms can be subdivided into the following: 1) the molecular mechanisms involved in preventing carcinogen metabolic activation, 2) the molecular mechanisms for preventing tumour cell proliferation by inactivation or downregulation of prooxidant enzymes or signal transduction enzymes, 3) the molecular cell death mechanisms for the induction of tumour cell death (apoptosis) and the molecular mechanisms for the inhibition of isolated mitochondria functions. Many of the flavonoids and polyphenols found in diets, supplements or herbal medicine were also ranked using "accelerated cytotoxic mechanism screening" by a combinatorial approach utilising isolated rat hepatocytes. A strong correlation of an early collapse of the mitochondrial membrane potential and cell death was found for most of the cytotoxic polyphenols but did not occur with non-toxic polyphenols. This screening could prove useful for eliminating polyphenols that have the potential for adverse health effects and for selecting safe and effective polyphenolic candidates for further development as supplements for preventing cancer or cardiovascular disease. Safety concerns of flavonoid/polyphenol supplements are also reviewed.
机译:这篇综述总结了在动物模型中类黄酮或多酚的使用阻止化学致癌作用时可能涉及的各种分子化学预防或治疗机制的当前知识。这些机制可细分为:1)预防致癌物代谢活化的分子机制,2)通过灭活或下调前氧化酶或信号转导酶防止肿瘤细胞增殖的分子机制,3)分子细胞死亡机制用于诱导肿瘤细胞死亡(细胞凋亡)和抑制孤立的线粒体功能的分子机制。饮食,补品或草药中发现的许多类黄酮和多酚也通过利用分离的大鼠肝细胞的组合方法,使用“加速细胞毒性机制筛选”进行排名。对于大多数细胞毒性多酚,线粒体膜电位的早期衰竭与细胞死亡之间存在很强的相关性,但对于非毒性多酚却没有发生。这种筛选可证明对消除可能对健康造成不良影响的多酚以及选择安全有效的多酚候选物作为预防癌症或心血管疾病的补充剂有待进一步开发有用。还审查了类黄酮/多酚补充剂的安全性问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号